德拉华州最高法院同意听取GSK的Zantac上诉,导致股票增长4%. Delaware Supreme Court agrees to hear GSK's Zantac appeal, leading to a 4% stock increase.
在特拉华州最高法院同意审理他们在Zantac案中的上诉后,GSK股票价格上涨。 GSK stock prices rose after the Delaware Supreme Court agreed to hear their appeal in the Zantac case. 这起案件涉及Zantac和仿制品中致癌杂质的指控, The case involves allegations of carcinogenic impurities in Zantac and generic versions, leading to recalls and scrutiny. 法院审理上诉的决定可能会影响正在进行的诉讼并吸引投资者的注意。 The court's decision to hear the appeal may influence ongoing litigation and attract investor attention. 由于该裁决有利,GSK股价上了4%. GSK shares increased 4% following the favorable ruling.